- Home
- ORMP vs BHST Comparison
ORMP vs BHST Comparison
Compare ORMP & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | BHST |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 117.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | BHST |
|---|---|---|
| Price | $3.45 | $4.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 324.8K | 39.3K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | ★ 7.18% | N/A |
| EPS Growth | ★ 838.25 | N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | $2,000,000.00 | ★ $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $1.82 | $4.72 |
| 52 Week High | $3.71 | $12.80 |
Technical Indicators
Market Signals| Indicator | ORMP | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 41.50 |
| Support Level | $3.33 | $4.82 |
| Resistance Level | $3.60 | $6.15 |
| Average True Range (ATR) | 0.22 | 0.47 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 43.48 | 8.89 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About BHST BioHarvest Sciences Inc.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.